Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Status:
Unknown status
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ibandronate and zoledronate may help relieve some of the symptoms caused by bone
metastases. It is not yet know whether ibandronate is more effective than zoledronate in
treating bone metastases from breast cancer.
PURPOSE: This randomized phase III trial is studying ibandronate to see how well it works
compared with zoledronate in treating patients with newly diagnosed bone metastases from
breast cancer.